MBX
MBX Biosciences, Inc.
60.90$
-3.1%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | |
| 98.0% | 99.2% | 99.5% | 99.1% | |
| 53.7% | 36.3% | 18.4% | 19.5% | |
| 94.2% | 95.8% | 97.6% | 97.0% | |
| 0.3% | 0.2% | 0.3% | 0.6% | |
| 194.5% | 186.1% | 4.1% | 4.1% | |
| 7.6% | 4.7% | 4.1% | 4.0% | |
| 0.3% | 0.2% | 0.1% | 0.0% | |
| 2.2% | 1.7% | 2.0% | 0.8% | |
| -94.5% | -86.1% | 95.9% | 95.9% | |
| -95.4% | -89.8% | -51.2% | -58.3% | |
| 70.6% | 37.8% | 12.4% | 9.5% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.